Oncosurgical Strategies for Unresectable Liver Metastases

作者: Robbert J. de Haas , Dennis A. Wicherts , René Adam

DOI: 10.1007/978-1-84628-947-7_7

关键词: ContraindicationInferior vena cavaRemnant liverHepatic resectionConcomitantChemotherapyResection marginRadiologyDiseaseMedicine

摘要: Negative prognostic factors for survival have been previously used to exclude patients from hepatic resection. For with colorectal metastases, these included high number and large size of the presence extrahepatic disease [4, 5]. The same considerations made regarding width resection margin Empirically, a 1 cm or more was as one important selection criteria metastases. Regardless fact that extensive tumor involvement is associated unfavorable outcome, long-term can be achieved in when complete performed both intrahepatic deposits. In addition, it has shown tumor-free importance than its [6]. The improved knowledge influence established impact on outcome resulted pragmatic definition unresectability. current practice, liver remnant too small relation extent needed achieve radicality only remaining indicator Patients are considered resectable long all metastases completely resected margins, while leaving at least 25–30% volume prevent postoperative insufficiency [7]. general, margins >1 recommended, but should not limit macroscopically complete. Additionally, no longer contraindication surgery. main causes responsible technical unresectability therefore multinodularity, vascular-ill location disease. In divided into three categories: 1. Easily resectable. this group, adequate oncological normal parenchyma. need exists improve resectability before proceeding surgery. 2. Marginally These present disease, limiting possibilities upfront Surgery may limited by difficulties achieving due involvement. Furthermore, major hepatectomy might endanger required 25–30%. Finally, concomitant also ascribed group. Different methods reduce load “curativity” resection. 3. Definitely unresectable. This group represents subset widespread usually disseminated over multiple metastatic sites. most cases, chemotherapy treatment intraoperative strategies mandatory control downsize technically enable curative surgery patients. Obviously, chance further decreases 3. However, owing increasing efficacy chemotherapy, some will switched complex and/or sequential surgery, even presenting initially “definitely”

参考文章(53)
Gavelli A, Huguet C, Lasserre M, Joseph Jm, Jobard J, Chieco Pa, Gramaglia M, Bona S, Harb J, Liver ischemia for hepatic resection: where is the limit? Surgery. ,vol. 111, pp. 251- 259 ,(1992)
A. de Gramont, Emmanuel Van Cutsem, J. Sastre, A. Cervantes, J. Van Laethem, Yves Humblet, E. Casac, A. Zubel, N. Gascon, Thibaut André, Cetuximab plus oxaliplatin/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFOX-4) for the epidermal growth factor receptor (EGFR)expressing metastatic colorectal cancer (mCRC) in the first-line setting: a phase II study Ejc Supplements. ,vol. 3, pp. 181- 182 ,(2005)
Michel Rivoire, Franco De Cian, Pierre Meeus, Sylvie Négrier, Henri Sebban, Pierre Kaemmerlen, Combination of neoadjuvant chemotherapy with cryotherapy and surgical resection for the treatment of unresectable liver metastases from colorectal carcinoma Cancer. ,vol. 95, pp. 2283- 2292 ,(2002) , 10.1002/CNCR.10973
HENRI BISMUTH, DENIS CASTING, O. JAMES GARDEN, Major hepatic resection under total vascular exclusion. Annals of Surgery. ,vol. 210, pp. 13- 19 ,(1989) , 10.1097/00000658-198907000-00002
R. Adam, T. Aloia, F. Levi, D.A. Wicherts, R.J. de Haas, B. Paule, M.P. Bralet, M. Bouchahda, D. Machover, M. Ducreux, V. Castagne, D. Azoulay, D. Castaing, Résection hépatique après traitement par agents ciblés de métastases hépatiques initialement non résécables n’ayant pas répondu à une chimiothérapie conventionnelle Journal De Chirurgie. ,vol. 145, pp. 76- ,(2008) , 10.1016/S0021-7697(08)70284-9
N. Selzner, B. C. Pestalozzi, Z. Kadry, M. Selzner, S. Wildermuth, P.-A. Clavien, Downstaging colorectal liver metastases by concomitant unilateral portal vein ligation and selective intra‐arterial chemotherapy British Journal of Surgery. ,vol. 93, pp. 587- 592 ,(2006) , 10.1002/BJS.5281
Francis L�vi, Rachid Zidani, Silvano Brienza, Luigi Dogliotti, Bruno Perpoint, Mathieu Rotarski, Yves Letourneau, Jean-Fran�ois Llory, Philippe Chollet, Annick Le Rol, Christian Focan, , A multicenter evaluation of intensified, ambulatory, chronomodulated chemotherapy with oxaliplatin, 5‐fluorouracil, and leucovorin as initial treatment of patients with metastatic colorectal carcinoma Cancer. ,vol. 85, pp. 2532- 2540 ,(1999) , 10.1002/(SICI)1097-0142(19990615)85:12<2532::AID-CNCR7>3.0.CO;2-1
Bernard Nordlinger, Marguerite Guiguet, Jean-Christophe Vaillant, Pierre Balladur, Karim Boudjema, Philippe Bachellier, Daniel Jaeck, Association Française de Chirurgie, Surgical resection of colorectal carcinoma metastases to the liver: A prognostic scoring system to improve case selection, based on 1568 patients Cancer. ,vol. 77, pp. 1254- 1262 ,(1996) , 10.1002/(SICI)1097-0142(19960401)77:7<1254::AID-CNCR5>3.0.CO;2-I
Daniel Azoulay, Denis Castaing, Alloua Smail, René Adam, Valérie Cailliez, Alexis Laurent, Antoinette Lemoine, Henri Bismuth, Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Annals of Surgery. ,vol. 231, pp. 480- 486 ,(2000) , 10.1097/00000658-200004000-00005
GLENN STEELE, T. S. RAVIKUMAR, Resection of hepatic metastases from colorectal cancer. Biologic perspective. Annals of Surgery. ,vol. 210, pp. 127- 138 ,(1989) , 10.1097/00000658-198908000-00001